UK PM Johnson: MHRA is already set to assess Novavax vaccine after phase 3 trials showed 89.3% efficacy

UK PM Johnson: MHRA is already set to assess Novavax vaccine after phase 3 trials showed 89.3% efficacy

FXstreet.com

Published

Read more on https://www.fxstreet.com

Full Article